Hormonal birth control for men has been a solved problem since the 1970s, and the current iterations of the technology are actually substantially superior to equivalent treatments for women, demonstrating higher effectiveness, less dangerous side effects, and lower prevalence of side effects in virtually all modern trials. At this point, some forty years on, such treatments continue to be refused certification on the ostensible basis of concerns over the purely hypothetical effects of long-term use.

Meanwhile, a hormonal birth control treatment for women whose known and documented side effects include “sudden death” can go from the laboratory to the pharmacy shelf in under five years.